Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020110067 - COMPOUNDS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE

Publication Number WO/2020/110067
Publication Date 04.06.2020
International Application No. PCT/IB2019/060302
International Filing Date 28.11.2019
IPC
A61K 38/17 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
A61P 25/16 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
14for treating abnormal movements, e.g. chorea, dyskinesia
16Anti-Parkinson drugs
CPC
A61K 38/177
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
177Receptors; Cell surface antigens; Cell surface determinants
A61P 25/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
14for treating abnormal movements, e.g. chorea, dyskinesia
16Anti-Parkinson drugs
Applicants
  • UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG [ZA]/[ZA]
  • UNIVERSITY OF CAPE TOWN [ZA]/[ZA]
Inventors
  • WEISS, Stefan Franz Thomas
  • VAN DER MERWE, Eloise
  • CUTTLER, Katelyn
  • BIGNOUX, Monique
  • BURNS, Jessica
  • PRINCE, Sharon
Agents
  • PEREIRA MARAIS
Priority Data
2018/0802528.11.2018ZA
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) COMPOUNDS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE
(FR) COMPOSÉS DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE LA MALADIE DE PARKINSON
Abstract
(EN)
The field of this invention relates to LRP/LR for use in the treatment and/or prevention of Parkinson's disease (PD). The invention extends to pharmaceutical compositions comprising LRP/LR for use in the treatment of Parkinson's Disease (PD), and extends to a method of maintaining concentration levels of dopamine within a human or animal body.
(FR)
L'invention concerne des composés LRP/LR destinés à être utilisés dans le traitement et/ou la prévention de la maladie de Parkinson. La présente invention concerne également des compositions pharmaceutiques contenant des composés LRP/LR destinés à être utilisés dans le traitement de la maladie de Parkinson (PD), ainsi qu'une méthode destinée à maintenir des niveaux de concentration de dopamine dans un corps humain ou animal.
Latest bibliographic data on file with the International Bureau